6811290|t|An antagonist-induced benzodiazepine abstinence syndrome.
6811290|a|Cats were treated for 35 days with flurazepam, 5 mg/kg per day. The drug was administered through a gastric fistula. Ro15-1788, a benzodiazepine antagonist, caused an abstinence syndrome when administered through the gastric fistula 24 h after the last dose of chronic treatment. Abstinence signs included increased muscle tone, tremor, piloerection, pupillary dilation, panting, and excessive salivation. Neither convulsions nor delirium was seen. Severity of abstinence was similar after Ro15-1788 doses of 2-100 mg/kg, but lasted longer (8-10 h) after the higher dose. Readministering Ro15-1788 a week after the end of chronic treatment precipitated an attenuated abstinence syndrome, but was inactive after 2 weeks.
6811290	22	56	benzodiazepine abstinence syndrome	Chemical	-
6811290	58	62	Cats	Species	9685
6811290	93	103	flurazepam	Chemical	MESH:D005479
6811290	158	173	gastric fistula	Disease	MESH:D005747
6811290	175	184	Ro15-1788	Chemical	MESH:D005442
6811290	188	202	benzodiazepine	Chemical	MESH:D001569
6811290	225	244	abstinence syndrome	Disease	MESH:D009357
6811290	275	290	gastric fistula	Disease	MESH:D005747
6811290	338	348	Abstinence	Disease	MESH:D009357
6811290	374	385	muscle tone	Disease	MESH:D009122
6811290	387	393	tremor	Disease	MESH:D014202
6811290	409	427	pupillary dilation	Disease	MESH:D002311
6811290	452	462	salivation	Disease	
6811290	472	483	convulsions	Disease	MESH:D012640
6811290	488	496	delirium	Disease	MESH:D003693
6811290	519	529	abstinence	Disease	MESH:D009357
6811290	548	557	Ro15-1788	Chemical	MESH:D005442
6811290	646	655	Ro15-1788	Chemical	MESH:D005442
6811290	725	744	abstinence syndrome	Disease	MESH:D009357
6811290	Negative_Correlation	MESH:D001569	MESH:D005442
6811290	Positive_Correlation	MESH:D005442	MESH:D009357
6811290	Positive_Correlation	MESH:D005442	MESH:D002311
6811290	Positive_Correlation	MESH:D005442	MESH:D014202
6811290	Positive_Correlation	MESH:D005442	MESH:D009122

